(VIANEWS) – Universal Technical Institute (UTI), Halozyme Therapeutics (HALO), Interactive Brokers Group (IBKR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Universal Technical Institute (UTI)
46% sales growth and 3.91% return on equity
Universal Technical Institute, Inc. provides transportation and technical training programs in the United States. It offers certificate, diploma, or degree programs under various brands, such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology. The company also provides manufacturer specific advanced training programs, including student paid electives at its campuses; and manufacturer or dealer sponsored training at various campuses and dedicated training centers, as well as offers programs for welding and CNC machining. As of September 30, 2022, it operated 16 campuses. Universal Technical Institute, Inc. was founded in 1965 and is headquartered in Phoenix, Arizona.
Earnings Per Share
As for profitability, Universal Technical Institute has a trailing twelve months EPS of $0.06.
PE Ratio
Universal Technical Institute has a trailing twelve months price to earnings ratio of 141.5. Meaning, the purchaser of the share is investing $141.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.91%.
2. Halozyme Therapeutics (HALO)
27.2% sales growth and 105.22% return on equity
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its flagship product is Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company also develops Perjeta; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; Centre for the AIDS Programme of Research in South Africa; and ViiV Healthcare Limited for small and large molecule targets for the treatment and prevention of HIV. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.
Earnings Per Share
As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $1.68.
PE Ratio
Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 23.25. Meaning, the purchaser of the share is investing $23.25 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 105.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 45.1%, now sitting on 773.65M for the twelve trailing months.
3. Interactive Brokers Group (IBKR)
16.5% sales growth and 20.78% return on equity
Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in routing, executing, and processing trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.
Earnings Per Share
As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $2.84.
PE Ratio
Interactive Brokers Group has a trailing twelve months price to earnings ratio of 31.47. Meaning, the purchaser of the share is investing $31.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.78%.
Yearly Top and Bottom Value
Interactive Brokers Group’s stock is valued at $89.28 at 16:22 EST, under its 52-week high of $95.59 and way higher than its 52-week low of $62.70.
Moving Average
Interactive Brokers Group’s value is below its 50-day moving average of $90.11 and higher than its 200-day moving average of $82.39.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Interactive Brokers Group’s EBITDA is 23.94.
4. Abercrombie & Fitch Company (ANF)
10.5% sales growth and 16.06% return on equity
Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer. The company operates in two segments, Hollister and Abercrombie. It offers an assortment of apparel, personal care products, intimates, and accessories for men, women, and children under the Hollister, Abercrombie & Fitch, abercrombie kids, Moose, Seagull, and Gilly Hicks brands. As of May 28, 2020, it operated approximately 850 stores in North America, Europe, Asia, and the Middle East. The company sells products through its stores and direct-to-consumer channels; various third-party wholesale, franchise, and licensing arrangements; and e-commerce platforms. Abercrombie & Fitch Co. was founded in 1892 and is headquartered in New Albany, Ohio.
Earnings Per Share
As for profitability, Abercrombie & Fitch Company has a trailing twelve months EPS of $2.12.
PE Ratio
Abercrombie & Fitch Company has a trailing twelve months price to earnings ratio of 23.71. Meaning, the purchaser of the share is investing $23.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Abercrombie & Fitch Company’s EBITDA is 0.81.
5. Aon plc (AON)
6.9% sales growth and 576.42% return on equity
Aon plc, a professional services firm, provides advice and solutions to clients focused on risk, retirement, and health worldwide. It offers commercial risk solutions, including retail brokerage, specialty solutions, global risk consulting and captives management, and affinity programs; and health solutions, such as health and benefits brokerages, and health care exchanges. The company also provides treaty and facultative reinsurance, as well as insurance-linked securities, capital raising, strategic advice, restructuring, and mergers and acquisitions services; and corporate finance advisory services. In addition, it offers strategic design consulting services on their retirement programs, actuarial services, and risk management services; advice services on developing and maintaining investment programs across a range of plan types, including defined benefit plans, defined contribution plans, endowments, and foundations for public and private companies, and other institutions; and advice and solutions that help clients in risk, health, and wealth through commercial risk, reinsurance, health, and wealth solutions. Aon plc was founded in 1919 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Aon plc has a trailing twelve months EPS of $12.86.
PE Ratio
Aon plc has a trailing twelve months price to earnings ratio of 25.5. Meaning, the purchaser of the share is investing $25.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 576.42%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 12.87B for the twelve trailing months.
6. Northern Technologies International Corporation (NTIC)
6.2% sales growth and 6.19% return on equity
Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of biobased and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.
Earnings Per Share
As for profitability, Northern Technologies International Corporation has a trailing twelve months EPS of $0.37.
PE Ratio
Northern Technologies International Corporation has a trailing twelve months price to earnings ratio of 36.14. Meaning, the purchaser of the share is investing $36.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.19%.
